Subject: EU Approves Inflectra , copycay Bio drug for RA
European regulators this month approved a biologically similar version of an antibody-based drug for treating rheumatoid arthritis, in a move with global implications. Essentially, the drug is a biosimilar copycat of Remicade, which is produced by Johnson & Johnson and Merck & Co. cheaper drugs maybe good news but they never end up as good as the originals http://www.medicaldaily.com/eu-approves-inflectra-rheumatoid-arthritis-first-biosimilar-antibody-drug-clears-path-greater-256269
|